Cardiac natriuretic peptides, obesity, and insulin resistance: Evidence from two community-based studies

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 10, 2011, Pages 3242-3249

  Khan, Abigail May ^a,c   Cheng, Susan ^a,d,e   Magnusson, Martin ^f   Larson, Martin G ^d,g   Newton Cheh, Christopher ^a,b,d,h   McCabe, Elizabeth L ^a,d   Coviello, Andrea D ^j   Florez, Jose C ^a,b,h   Fox, Caroline S ^d,e,i   Levy, Daniel ^d,i   Robins, Sander J ^d   Arora, Pankaj ^a   Bhasin, Shalender ^k   Lam, Carolyn S P ^k   Vasan, Ramachandran S ^d,j   Melander, Olle ^f   Wang, Thomas J ^a,l  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f LUND UNIVERSITY   (Sweden)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h USA   (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANDROGEN; NATRIURETIC FACTOR; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

ADULT; ANDROGENS; BODY MASS INDEX; COHORT STUDIES; DIET; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; OBESITY; PREDICTIVE VALUE OF TESTS; TESTOSTERONE;

EID: 80053532134     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1182     Document Type: Article

References (62)

1. Levin ER, Gardner DG, Samson WK 1998 Natriuretic peptides. N Engl J Med 339:321-328 (Pubitemid 28366422)
2. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O 1995 Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681
3. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M 2000 Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97:4239-4244 (Pubitemid 30226117)
4. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N 1997 Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94:14730-14735 (Pubitemid 28041442)
5. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A 1995 Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65-68
6. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, Guiducci C, Kathiresan S, Benjamin EJ, Struck J, Morgenthaler NG, Bergmann A, Blankenberg S, Kee F, Nilsson P, Yin X, Peltonen L, Vartiainen E, Salomaa V, Hirschhorn JN, Melander O, Wang TJ 2009 Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41:348-353
7. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS 2004 Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594-600 (Pubitemid 38198866)
8. Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS 2006 B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 152:1071-1076 (Pubitemid 44854793)
9. Khush KK, Gerber IL, McKeown B, Marcus G, Vessey J, Foster E, Chatterjee K, Michaels AD 2006 Obese patients have lower B-type and atrial natriuretic peptide levels compared with nonobese. Congest Heart Fail 12:85-90
10. St Peter JV, Hartley GG, Murakami MM, Apple FS 2006 B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem 52:680-685
11. Horwich TB, Hamilton MA, Fonarow GC 2006 B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47:85-90 (Pubitemid 43005169)
12. Rivera M, Cortés R, Salvador A, Bertomeu V, De Burgos FG, Pay áR, Portolés M, Taléns-Visconti R, Martinez-Dolz L, Valero R, Sevilla B, Climent V 2005 Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail 7:1168-1170 (Pubitemid 41721121)
13. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi Jr JL 2005 Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149:744-750
14. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians Jr FH, De Lemos JA 2005 Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112:2163-2168 (Pubitemid 41475811)
15. Dessì-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A 1997 Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 15:1695-1699 (Pubitemid 28029666)
16. Hanusch-Enserer U, Hermann KM, Cauza E, Spak M, Mähr B, Dunky A, Rosen HR, Köller U, Prager R 2003 Effect of gastric banding on aminoterminal pro-brain natriuretic peptide in the morbidly obese. Obes Res 11:695-698 (Pubitemid 41151595)
17. Hermann-Arnhof KM, Hanusch-Enserer U, Kaestenbauer T, Publig T, Dunky A, Rosen HR, Prager R, Köller U 2005 N-terminal pro- B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failure. Clin Chem 51:138-143 (Pubitemid 40024023)
18. Fernandes F, Ramires FJ, Buck PC, Almeida IJ, Rabelo R, Dantas SA, Salemi VM, Halpern A, Mady C 2007 N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity. Braz J Med Biol Res 40:153-158 (Pubitemid 46237847)
19. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, De Lemos JA 2007 Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol 49:109-116 (Pubitemid 46026905)
20. Lee TT, Cheng BH, Tsai EM, Yang CH, Chang Y, Li S, Lee JN 2003 Chronic administration of atrial natriuretic peptide reduces testosterone production of testes in mice. J Androl 24:912-917 (Pubitemid 37370548)
21. Halbirk M, Norrelund H, Moller N, Schmitz O, Botker HE,Wiggers H 2009 Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. Int J Cardiol 144:140-142
22. Dawber TR, Meadors GF, Moore Jr FE 1951 Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 41:279-281
23. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP 1979 An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110:281-290 (Pubitemid 10204328)
24. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, D'Agostino Sr RB, Fox CS, Larson MG, Murabito JM, O'Donnell CJ, Vasan RS, Wolf PA, Levy D 2007 The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165:1328-1335 (Pubitemid 47234329)
25. Rosvall M, Janzon L, Berglund G, Engström G, Hedblad B 2005 Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 257:430-437 (Pubitemid 40604547)
26. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ 2009 Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49-57
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
28. Rutter MK, Meigs JB, Sullivan LM, D'Agostino Sr RB, Wilson PW 2005 Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54:3252-3257 (Pubitemid 43334382)
29. Januzzi Jr JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB 2005 The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95:948-954 (Pubitemid 40487743)
30. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672 (Pubitemid 30645223)
31. Mazer NA 2009 A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 74:512-519
32. Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passeri M, Reaven GM 1992 Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med 231:235-240
33. Mohteshamzadeh M, Wilkinson R, Thomas SH 2005 Insulin resistance in men with treated hypertension at increased risk for cardiovascular disease: results of a 3-year study. Am J Hypertens 18:452-456
34. Reaven GM 2003 Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88:2399-2403 (Pubitemid 36724403)
35. Tassone F, Gianotti L, Rolfo F, Visconti G, Borretta G, Feola M 2009 B-type natriuretic peptide levels and insulin resistance in patients with severe ischemic myocardial dysfunction. J Endocrinol Invest 32:805-809
36. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jørgensen T, Hildebrandt P 2005 N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46:660-666 (Pubitemid 43186736)
37. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS 2007 Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115:1345-1353 (Pubitemid 46648370)
38. Nannipieri M, Seghieri G, Catalano C, Prontera T, Baldi S, Ferrannini E 2002 Defective regulation and action of atrial natriuretic peptide in type 2 diabetes. Horm Metab Res 34:265-270 (Pubitemid 34666591)
39. Miller JA, Abouchacra S, Zinman B, Skorecki KL, Logan AG 1993 Atrial natriuretic factor counteracts sodium-retaining actions of insulin in normal men. Am J Physiol 265:R584-R590 (Pubitemid 23295008)
40. Tanabe A, Naruse M, Wasada T, Naruse K, Yoshimoto T, Omori Y, Demura H 1995 Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur J Endocrinol 132:693-698
41. Clark BA, Sclater A, Epstein FH, Elahi D 1993 Effect of glucose, insulin, and hypertonicity on atrial natriuretic peptide levels in man. Metabolism 42:224-228 (Pubitemid 23051466)
42. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Kato Y, Saruta T 2001 Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects. J Hum Hypertens 15:393-399 (Pubitemid 32544716)
43. Sicard RE, Feit L, Werner JC 1993 Insulin reduces basal release of atrial natriuretic factor by isolated, perfused neonatal pig hearts. Biol Neonate 64:221-227 (Pubitemid 23322277)
44. Bai GY, Piao FL, Kim SY, Yuan K, Kim SZ, Kim SH 2006 Augmentation of insulin-stimulated ANP release through tyrosine kinase and PI 3-kinase in diabetic rats. Peptides 27:2756-2763 (Pubitemid 44584399)
45. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, Yamahara K, Taura D, Inuzuka M, Sonoyama T, Nakao K 2009 Natriuretic peptides/cGMP/cGMP- dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58:2880-2892
46. Sarzani R, Marcucci P, Salvi F, Bordicchia M, Espinosa E, Mucci L, Lorenzetti B, Minardi D, Muzzonigro G, Dessi-Fulgheri P, Rappelli A 2008 Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes (Lond) 32:259-267 (Pubitemid 351271787)
47. Sengenès C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J 2000 Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14:1345-1351 (Pubitemid 30439743)
48. Moro C, Klimcakova E, Lolmède K, Berlan M, Lafontan M, Stich V, Bouloumi é A, Galitzky J, Arner P, Langin D 2007 Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia 50:1038-1047 (Pubitemid 46559252)
49. Carlsson PO, Berne C, Jansson L 1998 Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127-133 (Pubitemid 28088387)
50. Meirhaeghe A, Sandhu MS, McCarthy MI, De Groote P, Cottel D, Arveiler D, Ferrierès J, Groves CJ, Hattersley AT, Hitman GA, Walker M, Wareham NJ, Amouyel P 2007 Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 16:1343-1350 (Pubitemid 47055130)
51. Choquet H, Cavalcanti-Proença C, Lecoeur C, Dina C, Cauchi S, Vaxillaire M, Hadjadj S, Horber F, Potoczna N, Charpentier G, Ruiz J, Hercberg S, Maimaitiming S, Roussel R, Boenhnke M, Jackson AU, Patsch W, Krempler F, Voight BF, Altshuler D, Groop L, Thorleifsson G, Steinthorsdottir V, Stefansson K, Balkau B, Froguel P, Meyre D 2009 The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet 18:2495-2501
52. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE 2004 Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 109:706-713 (Pubitemid 38222888)
53. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR 2008 The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the U.S. population (NHANES 1999-2004). Arch Intern Med 168:1617-1624
54. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, Poehlman ET 2004 Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 89:5013-5020 (Pubitemid 39391442)
55. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R 2005 The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90:4145-4150 (Pubitemid 41058189)
56. Ruderman NB, Schneider SH, Berchtold P 1981 The "metabolicallyobese, "normal-weight individual. Am J Clin Nutr 34:1617-1621
57. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G 2007 Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 30:2145-2147 (Pubitemid 47219439)
58. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB 2006 Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906-2912 (Pubitemid 44271734)
59. DeFronzo RA 1981 The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 21:165-171 (Pubitemid 11049307)
60. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M 2008 Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 21:733-741 (Pubitemid 351913612)
61. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, Rosenfeld RS 1990 Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 71:929-931
62. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, Liu K, Ouyang P 2007 Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 92:1289-1295 (Pubitemid 46556400)